Your browser doesn't support javascript.
loading
Clinical utility of topiramate extended-release capsules (USL255): Bioequivalence of USL255 sprinkled and intact capsule in healthy adults and an in vitro evaluation of sprinkle delivery via enteral feeding tubes.
Clark, Annie M; Pellock, John M; Holmay, Mary; Anders, Bob; Cloyd, James.
Affiliation
  • Clark AM; Upsher-Smith Laboratories, Inc., Maple Grove, MN, United States. Electronic address: Annie.Clark@upsher-smith.com.
  • Pellock JM; Virginia Commonwealth University, Division of Child Neurology, Richmond, VA, United States.
  • Holmay M; Upsher-Smith Laboratories, Inc., Maple Grove, MN, United States.
  • Anders B; Upsher-Smith Laboratories, Inc., Maple Grove, MN, United States.
  • Cloyd J; Center for Orphan Drug Research, University of Minnesota, Minneapolis, MN, United States.
Epilepsy Behav ; 57(Pt A): 105-110, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26943947
ABSTRACT

OBJECTIVE:

The objectives of these two studies were to determine if beads from extended-release topiramate capsules sprinkled onto soft food are bioequivalent to the intact capsule and if beads from the capsule can be passed through enteral gastrostomy (G-) and jejunostomy (J-) feeding tubes.

METHODS:

Bioequivalence of 200-mg USL255 (Qudexy XR [topiramate] extended-release capsules) sprinkled onto soft food (applesauce) versus the intact capsule was evaluated in a phase 1, randomized, single-dose, crossover study (N=36). Pharmacokinetic evaluations included area under the curve (AUC), maximum plasma concentration (Cmax), time to Cmax (Tmax), and terminal elimination half-life (t1/2). If 90% confidence intervals (CI) of the ratio of geometric least-squares means were between 0.80 and 1.25, AUC and Cmax were considered bioequivalent. In separate in vitro experiments, 100-mg USL255 beads were passed through feeding tubes using gentle syringe pressure to develop a clog-free bead-delivery method. Multiple tube sizes (14- to 18-French [Fr] tubes), dilutions (5 mg/15 mL-25 mg/15 mL), and diluents (deionized water, apple juice, Ketocal, sparkling water) were tested.

RESULTS:

Area under the curve and Cmax for USL255 beads sprinkled onto applesauce were bioequivalent to the intact capsule (GLSM [90% CI] AUC0-t 1.01 [0.97-1.04], AUC0-∞ 1.02 [0.98-1.05]; Cmax 1.09 [1.03-1.14]). Median Tmax was 4h earlier for USL255 sprinkled versus the intact capsule (10 vs 14 h; p=0.0018), and t1/2 was similar (84 vs 82 h, respectively). In 14-Fr G-tubes, USL255 beads diluted in Ketocal minimized bead clogging versus deionized water. Recovery of USL255 beads diluted in deionized water was nearly 100% in 16-Fr G-, 18-Fr G-, and 18-Fr J-tubes.

SIGNIFICANCE:

For patients with difficulty swallowing pills, USL255 sprinkled onto applesauce offers a useful once-daily option for taking topiramate. USL255 beads were also successfully delivered in vitro through ≥14-Fr G- or J-tubes, with tube clogging minimized by portioning the dose and using glidant diluents for smaller tubes.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Therapeutic Equivalency / Enteral Nutrition / Delayed-Action Preparations / Fructose / Anticonvulsants Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Therapeutic Equivalency / Enteral Nutrition / Delayed-Action Preparations / Fructose / Anticonvulsants Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 2016 Type: Article